Nymox Pharmaceutical (NYMXF) Non-Current Assets (2015 - 2025)
Nymox Pharmaceutical (NYMXF) reported Non-Current Assets of $1,000 for Q4 2025, unchanged from $1,000 a year earlier.
Powered by 
Analysis
Nymox Pharmaceutical (NYMXF) Non-Current Assets (2015 - 2025) Analysis & Trends
Dating back to Q4 2015, Nymox Pharmaceutical's Non-Current Assets record includes 30 quarters.
- Non-Current Assets has a five-year compound annual growth rate of -70.5% (FY2020 to FY2025).
- By year, Non-Current Assets came in at $1,000 in FY2024 (-50.0%), $2,000 in FY2023 (-98.8%), $168,000 in FY2022 (-58.6%) and $406,000 in FY2021 (-9.8%).
- Five-year quarterly Non-Current Assets spans a low of $1,000 in Q3 2024 and a high of $460,000 in Q3 2021.
- The high point for year-over-year Non-Current Assets in five years was Q3 2021 (growth of 329.9%); the low point was Q4 2023 (a decline of 98.8%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 77.61 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 141.07 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 101.45 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 125.00 Mn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 60.68 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 35.42 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 159.77 Bn |
| 10 | Nymox Pharmaceutical | 6.12 Mn | 5.93 Mn | - | 1,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 1,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Sep 30, 2024 | 1,000.00 |
| Dec 31, 2023 | 2,000.00 |
| Sep 30, 2023 | 15,000.00 |
| Jun 30, 2023 | 57,000.00 |
| Mar 31, 2023 | 114,000.00 |
| Dec 31, 2022 | 168,000.00 |
| Sep 30, 2022 | 230,000.00 |
| Jun 30, 2022 | 289,000.00 |
| Mar 31, 2022 | 348,000.00 |
| Dec 31, 2021 | 406,000.00 |
| Sep 30, 2021 | 460,000.00 |
| Jun 30, 2021 | 335,000.00 |
| Mar 31, 2021 | 394,000.00 |
| Dec 31, 2020 | 450,000.00 |
| Sep 30, 2020 | 107,000.00 |
| Jun 30, 2020 | 169,000.00 |
| Mar 31, 2020 | 237,000.00 |
| Dec 31, 2019 | 161,000.00 |
API Access
Nymox Pharmaceutical Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=NYMXF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "NYMXF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=NYMXF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();